Nextpower's backlog and its US tax-credit exposure are the whole thesis, and both are dated. The OBBBA required projects to BEGIN CONSTRUCTION by 2026-07-04 to keep the 48E/45Y continuity safe harbour - that deadline passed 25 days before this memo. FY2026's 20.3% growth was entirely US (+34.4%) while international revenue FELL 10.7%, the signature of a domestic policy rush; the most recent reported quarter (Q4 FY2026) declined 4.7% year-on-year and operating income fell 21.3%. Separately, $379.9m of Section 45X tax credit flows through cost of sales and supplies 54% of operating income: excluding it, FY2026 gross profit FELL $3.7m on revenue up 20.3%. Management has responded credibly - renaming from Nextracker, targeting one-third non-tracker revenue by FY30, and agreeing ~$750m of post-year-end acquisitions in battery storage (Prevalon) and German PV steel (Zimmermann) - but non-tracker is 12% of revenue against a credit that is 54% of operating income.
How to read this
This is an analysis, not a position. The memo scores every Criteria and blocks on none of them. Whether an analysis justifies a position is a question about a particular book, and two books answer it differently — so this page carries no Long, Short, Watchlist or Avoid verdict.
Every Criteria returns PASS / FAIL / INDETERMINATE, and carries a type. BINDING criteria are admission tests for a long-only absolute-return strategy. MEASURED criteria are always scored and stored, and never block — they inform timing, sizing or a future strategy. A missing input is INDETERMINATE, never FAIL.
Two valuation outputs, over two horizons. The implied-path test (reverse DCF) asks what today's price requires over five years and whether the business has demonstrated it; the 12-month target asks what the name is likely to trade at, on near-term estimates and the name's own multiple history. Neither replaces the other. Sensitivity is run over the exit multiple, never over scenario probabilities.
Momentum is entry timing only. It governs when to enter a position the thesis already justifies, never whether to own one.
Key findings
- THE COMPANY IS NO LONGER CALLED NEXTRACKER. The registrant's current legal name is Nextpower Inc.; SEC formerNames reads ['Nextracker Inc.', 'Nextracker LLC']. Renamed 2025-11-12 by charter amendment, alongside a FY30 target in which one-third of revenue comes from non-tracker products.
- THE POLICY DEADLINE HAS ALREADY PASSED. The OBBBA (enacted 2025-07-04) required projects to BEGIN CONSTRUCTION by 2026-07-04 to keep the four-year 48E/45Y continuity safe harbour; anything starting later must be placed in service by 2027-12-31. The deadline expired 25 days before this memo. The 10-K states the consequence in the company's own words: the acceleration 'will reduce the number of projects in future years... likely reducing the overall project volume over time.'
- THE PULL-FORWARD IS VISIBLE IN THE MIX. FY2026 revenue grew 20.3% - entirely US (+34.4%, from 69% to 77% of revenue) while international revenue FELL 10.7%. Volume grew 13% (38 GW vs 34 GW) against revenue up 20.3%.
- AND IT HAS ALREADY REVERSED. Q4 FY2026 revenue fell 4.7% year-on-year ($880.4m vs $924.3m) and 3.2% sequentially; Q4 operating income fell 21.3% ($153.7m vs $195.3m) and declined sequentially in every quarter of FY2026.
- THE COMPANY GUIDES DECELERATION. FY2027 revenue $3.8-4.1bn (+11.0%) with GAAP net income $501-559m and GAAP diluted EPS $3.19-3.56 - BELOW FY2026's $585.9m and $3.84. The FY30 target of $4.8-5.6bn implies +9.9%/yr, less than half the demonstrated 23.2%.
- ACCOUNTING-QUALITY FINDING: THE ENTIRE FY2026 GROSS-PROFIT GROWTH IS A TAX CREDIT. Section 45X vendor rebates recognised as a reduction of cost of sales went from $224.9m (FY2025) to $379.9m (FY2026), +$155.0m - against gross-profit growth of +$151.3m. EXCLUDING 45X, gross profit FELL $3.7m (-0.5%) on revenue up 20.3%, and gross margin fell from 26.5% to 21.9%.
- 45X supplies 10.7pp of a 19.6% operating margin - 54% of operating income. Excluding it, the FY2026 operating margin is 8.9%. The 10-K prints the phase-down: 100% through CY2029, then 75%/50%/25% in 2030/31/32, and ZERO after 2032. The step-down lands inside a five-year valuation window.
- BACKLOG FINDING: only 7.8% of it is an enforceable ASC 606 obligation. Company-defined backlog is 'over $5.25 billion'; the ASC 606 remaining performance obligation is $410.0m, of which ~75% is expected within 12 months and the long-term residual 'primarily relates to extended warranty and deposits collected in advance'. Backlog coverage of FY2027 guided revenue is 1.33x (from 1.26x); backlog DURATION is not disclosed at all.
- Cash conversion turned: CFO/net income 1.27x (FY2025) -> 0.96x (FY2026), driven by a $267.1m increase in the Section 45X credit receivable, which stands at $352.6m.
- Tariffs went from $19.7m to $130.4m (3.7% of revenue) and the 10-K says they were 'not fully included in pricing' - the named cause of the 150bp gross-margin decline.
- THE MECHANISM IS CREDIBLE AND EXPENSIVE. Non-tracker revenue went from ~8% to ~12% of the mix (+80% in dollars), with named products and evidence: record eBOS bookings including 100+ MW of NX PowerMerge, record TrueCapture revenue, 50+ GW cumulative NX Horizon-XTR, the first bundled VCA project incorporating robotics. Post-year-end the company agreed to buy Prevalon Energy (battery storage, up to $365m, 8-K 2026-05-28) and Zimmermann PV-Steel of Germany (up to EUR330m, 8-K 2026-06-22) - roughly $750m of consideration, ~$175m of it in new stock.
- MENTION-FREQUENCY FINDING: '45X' collapsed 86% in the quarterly earnings releases, from 40.5 to 5.6 mentions per 10,000 words, while the credit grew from $224.9m to $379.9m and became 54% of operating income. The drop happens in the FY26Q1 release, weeks after OBBBA. 'OBBBA' appears ZERO times in eight quarters of earnings releases, while the 10-K devotes pages to it. 'tariff' never exceeds 3.1 per 10k while the tariff line went to $130.4m. Meanwhile 'power conversion' went 0 -> 16.7, 'robotic' 0 -> 11.1, 'eBOS' 0 -> 13.9.
- SCREEN ERROR: share count. The screen used 136,542,423 against 150,274,472 outstanding and 152,710,033 diluted - 9.1% and 10.6% low, understating market cap by $1.31-1.54bn. The filed EPS refutes it directly ($585,883k / 136,542,423 = $4.29 against a filed $3.84).
- Correcting the share count, deducting the TRA, and deriving the terminal margin from the 45X statute moves the Valuation Criteria margin from the screen's +19.3pp to +12.4pp: required CAGR rises from 3.9% to 10.8%. Every screen error on this name ran in the direction of GENEROSITY - the opposite direction to the companion name in this run (RDDT), where every error ran toward harshness. The scanner's errors have no consistent sign.
Sections
Disclosed limitations
- Q1 FY2027 results (quarter ended ~2026-06-27) are NOT in this analysis. The latest filing is the FY2026 10-K (filed 2026-05-19), 71 days old. Prior-year analogues: 8-K 2025-07-29, 10-Q 2025-08-01. This is the FIRST quarter that will contain post-deadline order intake and it is the single most valuable missing datapoint.
- BACKLOG DURATION IS NOT DISCLOSED. No conversion schedule, no aging, no split between purchase orders and multi-year VCAs. Coverage is computable (1.33x FY2027 guided revenue); duration is not. Stated, not estimated.
- THE REVENUE CONTRIBUTION OF THE FOUR FY2026 ACQUISITIONS IS NOT DISCLOSED. Bentek, OnSight, Origami Solar and Fracsun are named with $117.2m of cash consideration but no pro-forma revenue disclosure was found, so organic growth cannot be separated from acquired growth. FY2026's 20.3% therefore OVERSTATES organic growth by an unquantified amount.
- NO STREET CONSENSUS was obtainable (Alpha Vantage EARNINGS_ESTIMATES, shared free-tier 25/day cap exhausted by parallel runs). Consensus Criteria is INDETERMINATE and blocks nothing. No Street figure is quoted anywhere. The FY2027 leg of NTM revenue is COMPANY GUIDANCE; the FY2028 leg is an interpolation between the FY2027 guide and the company's FY30 target and is the weaker leg.
- NO EARNINGS-CALL TRANSCRIPTS were obtainable (same quota). Mention frequency is computed instead on the quarterly earnings release furnished as Exhibit 99.1 to each Form 8-K Item 2.02 - eight consecutive quarters from EDGAR. Primary, dated, management-authored, but NOT a call transcript and carrying no analyst Q&A. Labelled as such at every point of use.
- Prevalon and Zimmermann financials are not disclosed in either 8-K - no target revenue, no margin, no closing date. Neither transaction has closed. The Zimmermann stock consideration is priced on a 30-day VWAP at closing, so the exact share issuance is unknown.
- WHETHER THE FY2026 BACKLOG WAS PULLED FORWARD IS AN INFERENCE, NOT A DISCLOSURE. The company does not disclose order dates against the 2026-07-04 deadline and no filing quantifies safe-harbour-driven ordering. The inference is drawn from the geography mix (all growth US, international down 10.7%), the Q4 YoY decline and the FY2027 guide - and is labelled as an inference.
- The exit multiple of 23.1x sits 16.1% ABOVE today's trading multiple of 19.8x. This makes the base test lenient rather than strict; the no-re-rating case (exit 19.8x, margin +8.8pp) is reported alongside it.
- Equity ADV is from the Alpaca IEX feed only - a single venue. $20.6m/day is a FLOOR, not an estimate of consolidated volume. No multiplier was applied because none could be evidenced.
- The growth-matched comparator set is drawn from the 4,018-name scan_all_v2 universe, whose individual per-name share counts are unaudited by this memo. The subject's own inputs were verified against filings; the peers' were not.